08 Jul 2026 Avacta Appoints Healthcare Executive Patrick Vink as Deputy Chairman of the Board of Directors Investors
25 Jun 2026 Avacta Reports Platform-Validating Data with Faridoxorubicin during BIO International Conference Investors | Therapeutics
25 Jun 2026 Avacta Announces U.S. FDA Agreement on Pivotal Trial Design for AVA6000 in Patients with Salivary Gland Cancer Investors | Therapeutics